2021 annual financial data
Kazia Therapeutics 2021 Operating margin
Direct answer
Operating margin was -41.99%.
Operating income was -6,376,000 AUD and net income was -8,420,000 AUD.
Operating cash flow was -9,111,000 AUD.
Get free Kazia Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 15,183,000 AUD
- Operating income
- -6,376,000 AUD
- Net income
- -8,420,000 AUD
- Operating cash flow
- -9,111,000 AUD